Risk factors for prolonged mechanical ventilation in critically ill patients with influenza-related acute respiratory distress syndrome

IF 4.7 2区 医学 Q1 RESPIRATORY SYSTEM Respiratory Research Pub Date : 2024-01-04 DOI:10.1186/s12931-023-02648-3
Pai-Chi Hsu, Yi-Tsung Lin, Kuo-Chin Kao, Chung-Kan Peng, Chau-Chyun Sheu, Shinn-Jye Liang, Ming-Cheng Chan, Hao-Chien Wang, Yu-Mu Chen, Wei-Chih Chen, Kuang-Yao Yang
{"title":"Risk factors for prolonged mechanical ventilation in critically ill patients with influenza-related acute respiratory distress syndrome","authors":"Pai-Chi Hsu, Yi-Tsung Lin, Kuo-Chin Kao, Chung-Kan Peng, Chau-Chyun Sheu, Shinn-Jye Liang, Ming-Cheng Chan, Hao-Chien Wang, Yu-Mu Chen, Wei-Chih Chen, Kuang-Yao Yang","doi":"10.1186/s12931-023-02648-3","DOIUrl":null,"url":null,"abstract":"Patients with influenza-related acute respiratory distress syndrome (ARDS) are critically ill and require mechanical ventilation (MV) support. Prolonged mechanical ventilation (PMV) is often seen in these cases and the optimal management strategy is not established. This study aimed to investigate risk factors for PMV and factors related to weaning failure in these patients. This retrospective cohort study was conducted by eight medical centers in Taiwan. All patients in the intensive care unit with virology-proven influenza-related ARDS requiring invasive MV from January 1 to March 31, 2016, were included. Demographic data, critical illness data and clinical outcomes were collected and analyzed. PMV is defined as mechanical ventilation use for more than 21 days. There were 263 patients with influenza-related ARDS requiring invasive MV enrolled during the study period. Seventy-eight patients had PMV. The final weaning rate was 68.8% during 60 days of observation. The mortality rate in PMV group was 39.7%. Risk factors for PMV were body mass index (BMI) > 25 (kg/m2) [odds ratio (OR) 2.087; 95% confidence interval (CI) 1.006–4.329], extracorporeal membrane oxygenation (ECMO) use (OR 6.181; 95% CI 2.338–16.336), combined bacterial pneumonia (OR 4.115; 95% CI 2.002–8.456) and neuromuscular blockade use over 48 h (OR 2.8; 95% CI 1.334–5.879). In addition, risk factors for weaning failure in PMV patients were ECMO (OR 5.05; 95% CI 1.75–14.58) use and bacteremia (OR 3.91; 95% CI 1.20–12.69). Patients with influenza-related ARDS and PMV have a high mortality rate. Risk factors for PMV include BMI > 25, ECMO use, combined bacterial pneumonia and neuromuscular blockade use over 48 h. In addition, ECMO use and bacteremia predict unsuccessful weaning in PMV patients.","PeriodicalId":21109,"journal":{"name":"Respiratory Research","volume":"29 1","pages":""},"PeriodicalIF":4.7000,"publicationDate":"2024-01-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Respiratory Research","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1186/s12931-023-02648-3","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"RESPIRATORY SYSTEM","Score":null,"Total":0}
引用次数: 0

Abstract

Patients with influenza-related acute respiratory distress syndrome (ARDS) are critically ill and require mechanical ventilation (MV) support. Prolonged mechanical ventilation (PMV) is often seen in these cases and the optimal management strategy is not established. This study aimed to investigate risk factors for PMV and factors related to weaning failure in these patients. This retrospective cohort study was conducted by eight medical centers in Taiwan. All patients in the intensive care unit with virology-proven influenza-related ARDS requiring invasive MV from January 1 to March 31, 2016, were included. Demographic data, critical illness data and clinical outcomes were collected and analyzed. PMV is defined as mechanical ventilation use for more than 21 days. There were 263 patients with influenza-related ARDS requiring invasive MV enrolled during the study period. Seventy-eight patients had PMV. The final weaning rate was 68.8% during 60 days of observation. The mortality rate in PMV group was 39.7%. Risk factors for PMV were body mass index (BMI) > 25 (kg/m2) [odds ratio (OR) 2.087; 95% confidence interval (CI) 1.006–4.329], extracorporeal membrane oxygenation (ECMO) use (OR 6.181; 95% CI 2.338–16.336), combined bacterial pneumonia (OR 4.115; 95% CI 2.002–8.456) and neuromuscular blockade use over 48 h (OR 2.8; 95% CI 1.334–5.879). In addition, risk factors for weaning failure in PMV patients were ECMO (OR 5.05; 95% CI 1.75–14.58) use and bacteremia (OR 3.91; 95% CI 1.20–12.69). Patients with influenza-related ARDS and PMV have a high mortality rate. Risk factors for PMV include BMI > 25, ECMO use, combined bacterial pneumonia and neuromuscular blockade use over 48 h. In addition, ECMO use and bacteremia predict unsuccessful weaning in PMV patients.
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
流感相关急性呼吸窘迫综合征重症患者长期机械通气的风险因素
流感相关急性呼吸窘迫综合征(ARDS)患者病情危重,需要机械通气(MV)支持。在这些病例中经常出现长时间机械通气(PMV),而最佳的管理策略尚未确定。本研究旨在调查这些患者出现 PMV 的风险因素以及与断奶失败相关的因素。这项回顾性队列研究由台湾八家医疗中心开展。研究纳入了 2016 年 1 月 1 日至 3 月 31 日期间重症监护病房中所有经病毒学证实患有流感相关 ARDS 并需要进行侵入性 MV 的患者。收集并分析了人口统计学数据、危重症数据和临床结果。PMV 的定义是使用机械通气超过 21 天。在研究期间,共有 263 名流感相关 ARDS 患者接受了需要侵入性 MV 的治疗。78 名患者接受了 PMV。在 60 天的观察期间,最终断流率为 68.8%。PMV 组的死亡率为 39.7%。PMV 的风险因素包括体重指数(BMI)大于 25(kg/m2)[几率比(OR)2.087;95% 置信区间(CI)1.006-4.329]、使用体外膜氧合(ECMO)(OR 6.181;95% CI 2.338-16.336)、合并细菌性肺炎(OR 4.115;95% CI 2.002-8.456)和使用神经肌肉阻滞剂超过 48 小时(OR 2.8;95% CI 1.334-5.879)。此外,PMV 患者断奶失败的风险因素还包括使用 ECMO(OR 5.05;95% CI 1.75-14.58)和菌血症(OR 3.91;95% CI 1.20-12.69)。流感相关 ARDS 和 PMV 患者的死亡率很高。PMV 的风险因素包括体重指数大于 25、使用 ECMO、合并细菌性肺炎和使用神经肌肉阻滞剂超过 48 小时。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
Respiratory Research
Respiratory Research 医学-呼吸系统
自引率
1.70%
发文量
314
期刊介绍: Respiratory Research publishes high-quality clinical and basic research, review and commentary articles on all aspects of respiratory medicine and related diseases. As the leading fully open access journal in the field, Respiratory Research provides an essential resource for pulmonologists, allergists, immunologists and other physicians, researchers, healthcare workers and medical students with worldwide dissemination of articles resulting in high visibility and generating international discussion. Topics of specific interest include asthma, chronic obstructive pulmonary disease, cystic fibrosis, genetics, infectious diseases, interstitial lung diseases, lung development, lung tumors, occupational and environmental factors, pulmonary circulation, pulmonary pharmacology and therapeutics, respiratory immunology, respiratory physiology, and sleep-related respiratory problems.
期刊最新文献
Metabolomic characterization of COVID-19 survivors in Jilin province Serum tumor markers: potential indicators for occult lymph node metastasis in clinical T1 − 2N0M0 small cell lung cancer patients Reference values for exhaled nitric oxide in healthy children aged 6–18 years in China: a cross-sectional, multicenter clinical study An algorithm for discontinuing mechanical ventilation in boys with x-linked myotubular myopathy after positive response to gene therapy: the ASPIRO experience Effect of low climate impact vs. high climate impact inhalers for patients with asthma and COPD-a nationwide cohort analysis
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1